Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CG-8020 + CG-2505
- Development stage
- Unknown
- Lead developer
- ANI Pharmaceuticals
- Modality
- Cell Therapies
- Administration
- Intradermal
01
Overview
CG-8020 + CG-2505 is an investigational combination of two autologous cell-based cancer vaccines originally developed by Cell Genesys for pancreatic cancer. Public records list it as a cell therapy studied in a Phase 2 clinical trial in nonresectable or metastatic pancreatic cancer; however, detailed compositions and mechanisms for CG-8020 and CG-2505 have not been disclosed in the available registry summaries. The trial aimed to evaluate safety and effectiveness of administering CG-8020 with CG-2505 in this population. Given the sponsor (Cell Genesys) and the period, these candidates likely represent autologous tumor cell or antigen-presenting cell vaccines engineered to enhance anti-tumor immunity, but specific targets and constructs are not confirmed in accessible sources.
- Other names
- CG8020 + CG2505
Beyond the preview
Go deeper on CG-8020 + CG-2505.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CG-8020 + CG-2505.